sr 33557 has been researched along with Angor Pectoris in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glasser, SP; Humen, DP; Singh, SN | 1 |
1 trial(s) available for sr 33557 and Angor Pectoris
| Article | Year |
|---|---|
Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Fantofarone Study Group.
Topics: Adolescent; Aged; Analysis of Variance; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Indolizines; Male; Middle Aged; Phenethylamines | 1997 |